DDX53 and Splenomegaly: We observed that mice bearing CT26-GM-CSF tumors showed splenomegaly (Fig. 3A-3B) and moreover, that CT26-GM-CSF tumors hardly progressed after day 12, although the growth of unmodified CT26 or CT26-GM-CSF tumor cells initially followed a similar pattern (Fig. 3C).